Research Lobe Sciences partners with iNGENū for new clinical trials in Australia Canadian biopharmaceutical company will receive government tax incentive for studies down under Rowan DunneAugust 12, 2022
Psychedelics Serenus Global becomes Health Canada licensed psilocybin distributor Multi-disciplinary controlled substance company set to commence operations at Calgary facility Rowan DunneAugust 11, 2022
Industry update Green Flower to offer cannabis education via Worcester Polytechnic Flexible new curriculum designed to help students into cannabis career paths Rowan DunneJuly 13, 2022
Psychedelics Filament Health undertakes innovative clinical trial FDA-approved psilocin study in California said to be first of its kind for industry Rowan DunneJuly 11, 2022
Psychedelics PhD graduates from UBC launch new company in Nevada Married couple now run state-of-the-art laboratory in Las Vegas dedicated to advancing psychedelic therapies Rowan DunneJuly 8, 2022
Psychedelics Nirvana Life acquires exclusive license for novel psychedelic delivery system Canadian life sciences outfit continues to push the envelope in the clinical psychedelic sector Rowan DunneJuly 6, 2022
Psychedelics MAPS has immense fundraising success Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction Rowan DunneJuly 4, 2022
Psychedelics Mindset Pharma develops patent-pending new technology Company announces development of novel intranasal formulation with promising efficacy Rowan DunneJune 30, 2022
Medical and Pharmaceutical InMed Pharmaceuticals publicizes new peer-reviewed study New academic journal spotlights potential for rare cannabinoids to treat skin conditions Rowan DunneJune 20, 2022
Business Entheon Biomedical hands off DMT clinical study to Cybin Dimethyltryptamine continues to demonstrate tremendous therapeutic potential Rowan DunneJune 14, 2022